These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16898908

  • 1. A prospective evaluation of the cost of psoriasis in Spain (EPIDERMA project: phase II).
    Carrascosa JM, Pujol R, Daudén E, Hernanz-Hermosa JM, Bordas X, Smandia JA, Ferrándiz C.
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):840-5. PubMed ID: 16898908
    [Abstract] [Full Text] [Related]

  • 2. Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany.
    Berger K, Ehlken B, Kugland B, Augustin M.
    J Dtsch Dermatol Ges; 2005 Jul; 3(7):511-8. PubMed ID: 15967010
    [Abstract] [Full Text] [Related]

  • 3. The impact of psoriasis on health care costs and patient work loss.
    Fowler JF, Duh MS, Rovba L, Buteau S, Pinheiro L, Lobo F, Sung J, Doyle JJ, Swensen A, Mallett DA, Kosicki G.
    J Am Acad Dermatol; 2008 Nov; 59(5):772-80. PubMed ID: 19119095
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Direct and indirect costs attributable to osteoarthritis in active subjects.
    Rabenda V, Manette C, Lemmens R, Mariani AM, Struvay N, Reginster JY.
    J Rheumatol; 2006 Jun; 33(6):1152-8. PubMed ID: 16755664
    [Abstract] [Full Text] [Related]

  • 6. Economic burden of psoriasis compared to the general population and stratified by disease severity.
    Yu AP, Tang J, Xie J, Wu EQ, Gupta SR, Bao Y, Mulani PM.
    Curr Med Res Opin; 2009 Oct; 25(10):2429-38. PubMed ID: 19663687
    [Abstract] [Full Text] [Related]

  • 7. [Cost-effectiveness analysis comparing methotrexate with PUVA therapy for moderate-severe psoriasis in the sanitary area of Badajoz].
    de Argila D, Rodríguez-Nevado I, Chaves A.
    Actas Dermosifiliogr; 2007 Oct; 98(1):35-41. PubMed ID: 17374331
    [Abstract] [Full Text] [Related]

  • 8. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.
    Schöffski O, Augustin M, Prinz J, Rauner K, Schubert E, Sohn S, Reich K.
    J Dtsch Dermatol Ges; 2007 Mar; 5(3):209-18. PubMed ID: 17338796
    [Abstract] [Full Text] [Related]

  • 9. Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United States.
    Kulkarni AS, Balkrishnan R, Richmond D, Pearce DJ, Feldman SR.
    J Am Acad Dermatol; 2005 Jan; 52(1):27-31. PubMed ID: 15627077
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis.
    Bhosle MJ, Feldman SR, Camacho FT, Timothy Whitmire J, Nahata MC, Balkrishnan R.
    J Dermatolog Treat; 2006 Jan; 17(5):294-301. PubMed ID: 17092860
    [Abstract] [Full Text] [Related]

  • 14. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G, Berg J, Lindgren P, Gerfin A, Lutz J.
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.